Tonix Pharmaceuticals Holding Corp. Logo

Tonix Pharmaceuticals Holding Corp.

Develops therapies and vaccines for complex conditions and public health challenges.

TNXP | US

Overview

Corporate Details

ISIN(s):
US8902608392
LEI:
Country:
United States of America
Address:
26 MAIN STREET, SUITE 101, 7928 CHATHAM
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company that develops therapies and vaccines for complex, chronic conditions and public health challenges. The company's pipeline is focused on four main therapeutic areas: Central Nervous System (CNS) disorders, immunology, infectious diseases, and rare diseases. Key development programs include treatments for acute stress disorder, organ transplant rejection, Prader-Willi syndrome, and various cancers. Tonix also utilizes an in-house live virus vaccine platform to develop biodefense countermeasures against pathogens such as mpox and smallpox. The company's approach is centered on addressing unmet medical needs through scientific development of its portfolio of investigational product candidates.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Tonix Pharmaceuticals Holding Corp. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Tonix Pharmaceuticals Holding Corp.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Tonix Pharmaceuticals Holding Corp. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
BELITE BIO, INC Logo
Developing novel oral therapies for retinal degenerative eye diseases like GA and Stargardt disease.
United States of America BLTE
Benchmark Holdings Plc Logo
Aquaculture biotech providing nutrition and health solutions for sustainable farming.
United Kingdom BMK
Benitec Biopharma Inc. Logo
Develops ddRNAi gene therapies to silence genes causing chronic, life-threatening diseases.
United States of America BNTC
BeOne Medicines Ltd. Logo
Develops innovative and accessible cancer treatments for patients worldwide.
United States of America ONC
BGM Group Ltd. Logo
A pharma holding co. making APIs & TCM derivatives via bio-fermentation and extraction.
United States of America BGM
Bicara Therapeutics Inc. Logo
Developing first-in-class, dual-action bifunctional therapies for solid tumor patients.
United States of America BCAX
BICYCLE THERAPEUTICS PLC Logo
Developing novel bicyclic peptide medicines to precisely target hard-to-treat cancers.
United States of America BCYC
BIFIDO. Co. Ltd Logo
Biotech firm specializing in microbiome R&D for functional foods and cosmeceuticals.
South Korea 238200
BioAge Labs, Inc. Logo
Develops therapies for metabolic diseases like obesity by targeting the biology of human aging.
United States of America BIOA
BioArctic Logo
Develops treatments and diagnostics for neurodegenerative disorders like Alzheimer's and Parkinson's.
Sweden BIOA

Talk to a Data Expert

Have a question? We'll get back to you promptly.